Olaparib Combined With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(18)30365-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2018
Authors
Publisher
Elsevier BV